Clinical Outcomes Following Primary Intracerebral Hemorrhage

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Aug 9, 2024

Keywords

ClinConnect Summary

This clinical trial is looking into the experiences and outcomes of adults in China who have suffered from a type of stroke called primary intracerebral hemorrhage (ICH), which is when there is bleeding inside the brain. The researchers aim to gather important data about how common this condition is, what it looks like in patients, how to assess risks, the costs of treatment, and overall recovery. By studying this, they hope to improve the understanding and care of patients with ICH.

To participate in this study, you must be an adult who has been admitted to the hospital for primary ICH and has undergone certain tests, including a blood test and a CT scan, right after arriving. It's important to note that patients who have had previous brain issues or specific conditions that led to their ICH, or those who have had certain treatments, will not be eligible. If you join the study, you can expect to be part of a group that helps researchers learn more about this serious condition, and your experiences will contribute to better treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - We included adult patients who (1) admitted for primary ICH ; (2) underwent blood routine test (hemoglobin included) and CT scan as soon as they arrived at hospital; (3) were not treated with neurosurgical procedures.
• Exclusion Criteria:
• • We excluded patients who (1) had ICH secondary to known causes, including trauma, intracranial neoplasm and systemic diseases12, as well as anticoagulative agents; or had isolated intraventricular hemorrhage (IVH); (2) mRS \>2 before the current ICH episode (according to past medical records or description from guardians.